Femasys (FEMY) News Today $1.09 -0.01 (-0.91%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Femasys’s Strategic Partnerships and Market Expansion Drive Buy RatingDecember 5, 2024 | markets.businessinsider.comFemasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeedDecember 4, 2024 | theglobeandmail.comThe Latest Analyst Ratings For FemasysNovember 27, 2024 | benzinga.comFemasys announces peer-reviewed data from FemaSeed ITI in JGRMNovember 27, 2024 | markets.businessinsider.comBuy Recommendation for Femasys Driven by Promising FemaSeed Study Results and Market PotentialNovember 27, 2024 | markets.businessinsider.comFemasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility TreatmentNovember 26, 2024 | globenewswire.comFemasys’s Strategic Growth: Innovative Product Launches and Expansions in Women’s HealthNovember 15, 2024 | markets.businessinsider.comPromising Outlook for Femasys Amid Strategic Partnerships and Product AdvancementsNovember 13, 2024 | markets.businessinsider.comFemasys price target lowered to $8 from $10 at ChardanNovember 13, 2024 | msn.comFemasys’s Strong U.S. Launch and International Expansion Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comFemasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comFemasys to Exhibit at the Annual AAGL 2024 Global ConferenceNovember 8, 2024 | markets.businessinsider.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 2, 2024 | theglobeandmail.comFemasys issued U.S. patent covering FemBloc deviceNovember 2, 2024 | msn.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 1, 2024 | globenewswire.comFemasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeedOctober 31, 2024 | finance.yahoo.comStrategic Partnerships and Market Potential Drive Positive Outlook for FemaSeed Amidst RisksOctober 31, 2024 | markets.businessinsider.comFemasys announces partnership with Boston IVFOctober 31, 2024 | markets.businessinsider.comFemasys Advances in Women’s Health InnovationOctober 29, 2024 | markets.businessinsider.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education ProgramOctober 10, 2024 | finance.yahoo.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education ProgramOctober 10, 2024 | globenewswire.comFemasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | globenewswire.comFemasys Announces Infertility Clinic Customers from Coast to CoastSeptember 18, 2024 | globenewswire.comFemasys’s Strategic Expansion and Market Potential Bolster Buy RatingSeptember 13, 2024 | markets.businessinsider.comFemasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)September 12, 2024 | benzinga.comFemasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish MarketSeptember 11, 2024 | globenewswire.comFemasys Receives 510(k) Clearance From FDA To Market FemChec For Fallopian Tube DiagnosisSeptember 10, 2024 | markets.businessinsider.comFemasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube CheckSeptember 9, 2024 | globenewswire.comFemasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual MeetingSeptember 5, 2024 | markets.businessinsider.comFemasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual MeetingSeptember 5, 2024 | globenewswire.comFemasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comFemasys Inc.: Femasys Announces CE Mark and Canadian Approval for FemVue MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | finanznachrichten.deFemasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | globenewswire.comFemasys Hosts Congresswoman Lucy McBath at Georgia HeadquartersAugust 27, 2024 | globenewswire.comFemasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateAugust 8, 2024 | globenewswire.comFemasys to Participate in European Society of Human Reproduction and Embryology 40th Annual Meeting in AmsterdamJune 27, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeMay 17, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Office of Science and Technology Policy to Discuss the Cancer Moonshot InitiativeMay 17, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy CouncilMay 16, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with the White House's Gender Policy CouncilMay 16, 2024 | globenewswire.comFemasys’s Buy Rating Affirmed by Analyst Jason McCarthy on FemaSeed’s Market Success and Robust Clinical TrialsMay 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Hookipa Pharma (HOOK) and Femasys (FEMY)May 9, 2024 | markets.businessinsider.comFEMY Stock Earnings: Femasys Beats EPS, Misses Revenue for Q1 2024May 9, 2024 | investorplace.comFemasys Announces Financial Results for Quarter Ended March 31, 2024 and Provides Corporate UpdateMay 9, 2024 | globenewswire.comFemasys Expands Commercial Management Team with Addition of Experienced New HiresMay 7, 2024 | globenewswire.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women’s Healthcare InitiativesApril 18, 2024 | finance.yahoo.comFemasys CEO and Founder Kathy Lee-Sepsick Meets with Members of Congress to Raise Awareness of the Company and Discuss Women's Healthcare InitiativesApril 18, 2024 | globenewswire.comFemasys (FEMY) Price Target Increased by 5.41% to 9.95April 17, 2024 | msn.com Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now FEMY Media Mentions By Week FEMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼0.000.61▲Average Medical News Sentiment FEMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼01▲FEMY Articles Average Week Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fractyl Health News FONAR News electroCore News Monogram Orthopaedics News LENSAR News Edap Tms News InspireMD News Vivani Medical News Hyperfine News Apyx Medical News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FEMY Stock Alerts